Duolingo vs Doximity
Duolingo gamifies language learning for hundreds of millions of users on a freemium app, while Doximity built a professional network and communication platform specifically for U.S. physicians. Both companies scaled quickly by owning a captive audience that competitors find hard to poach, and both carry enviable gross margins from their software-first models. The Duolingo vs Doximity comparison examines paid subscriber growth, EBITDA conversion, and which platform has the cleaner path to sustained profitability.
Duolingo gamifies language learning for hundreds of millions of users on a freemium app, while Doximity built a professional network and communication platform specifically for U.S. physicians. Both c...
Investment Analysis
Duolingo
DUOL
Pros
- Strong analyst consensus with a 'Buy' rating and an average price target suggesting nearly 96% upside over the next year.
- Growing revenue base with $811 million trailing twelve months revenue and positive net profit of $96.8 million, indicating operational progress.
- Return on equity (ROE) of 11.3% signals reasonable profitability relative to shareholder equity.
Considerations
- High valuation metrics with a price-to-earnings (P/E) ratio of 181.8 suggest stock may be expensive compared to earnings.
- Recent sharp stock price drop around 27% following cautious guidance on bookings raises concerns over growth sustainability.
- Operating margin is low at 4.1%, reflecting limited profitability efficiency despite revenue growth.
Doximity
DOCS
Pros
- Market capitalization near $11.7 billion indicates significant scale and investor interest in Doximity.
- Positioned in a specialised healthcare communications sector with potential for growth driven by digital adoption.
- Recent public market presence allows for clearer financial transparency and comparable performance insights.
Considerations
- Limited publicly available detailed financial metrics within the last 12 months make current performance evaluation difficult.
- Exposure to healthcare regulatory and reimbursement changes could present macro-level operational risks.
- Competition in digital health communications is rising, which can pressure user acquisition and revenue growth.
Buy DUOL or DOCS in Nemo
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
